New Zealand markets closed

Enzychem Lifesciences Corporation (183490.KQ)

KOSDAQ - KOSDAQ Delayed price. Currency in KRW
Add to watchlist
1,830.00-43.00 (-2.30%)
At close: 03:30PM KST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-8,010,090
-9,326,412
-25,093,110
-27,864,833
-17,506,928
-
Depreciation & amortisation
-
3,512,019
2,389,005
2,111,007
2,035,899
-
Stock-based compensation
-
54,335
-306,117
711,906
50,348
-
Change in working capital
-
-6,504,071
-3,210,185
-1,748,066
2,143,700
-
Inventory
-
-4,574,324
-1,439,073
822,732
-1,331,207
-
Other working capital
-
-12,560,301
-22,332,574
-24,471,540
-17,117,478
-
Other non-cash items
-
-4,754,892
6,295,946
8,426,353
733,123
-
Net cash provided by operating activities
-
-10,257,940
-14,319,894
-18,588,946
-14,020,852
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-2,302,361
-8,012,681
-5,882,594
-3,096,626
-
Acquisitions, net
-
-920,526
-
-600,000
-
-3,000,000
Purchases of investments
-
-454,588,937
-231,127,771
-119,223,358
-109,485,396
-
Sales/maturities of investments
-
517,281,518
137,757,771
116,158,011
65,415,940
-
Other investing activities
-
-139,249
-7,428,657
-240,884
183,104
-
Net cash used for investing activities
-
53,561,538
-109,233,036
-9,728,674
-45,241,978
-
Net change in cash
-
7,786,590
4,867,725
958,310
-448,303
-
Cash at beginning of period
-
7,683,635
2,815,910
1,857,600
2,305,903
-
Cash at end of period
-
15,470,224
7,683,635
2,815,910
1,857,600
-
Free cash flow
Operating cash flow
-
-10,257,940
-14,319,894
-18,588,946
-14,020,852
-
Capital expenditure
-
-2,302,361
-8,012,681
-5,882,594
-3,096,626
-
Free cash flow
-
-12,560,301
-22,332,574
-24,471,540
-17,117,478
-